Syros Pharmaceuticals Pink Sheet Forward View

Syros Pharmaceuticals Additional Predictive Modules

Most predictive techniques to examine Syros price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Syros using various technical indicators. When you analyze Syros charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur. A naive forecasting model for Syros Pharmaceuticals is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of Syros Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

Syros Pharmaceuticals Naive Prediction Price Forecast For the 1st of February

Given 90 days horizon, the Naive Prediction forecasted value of Syros Pharmaceuticals on the next trading day is expected to be 0.0009 with a mean absolute deviation of 0.0001, mean absolute percentage error of 0.00000003, and the sum of the absolute errors of 0.01.

Syros Pharmaceuticals Pink Sheet Forecast Pattern

Backtest Syros Pharmaceuticals

Syros Pharmaceuticals Price Prediction

Buy or Sell Advice

Syros Pharmaceuticals Forecasted Value

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Syros Pharmaceuticals pink sheet data series using in forecasting. Note that when a statistical model is used to represent Syros Pharmaceuticals pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality. This model is not at all useful as a medium-long range forecasting tool of Syros Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict Syros Pharmaceuticals. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for Syros Pharmaceuticals

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Syros Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.

Hype Prediction Low Estimated High 0.00 0.0008 50.04 Details

Intrinsic Valuation Low Real High 0.00 0.0007 50.04 Details

Bollinger Band Projection (param) Low Middle High -0.0001 0.0004 0.0009 Details

Syros Pharmaceuticals After-Hype Price Density Analysis

Syros Pharmaceuticals Estimiated After-Hype Price Volatility

Syros Pharmaceuticals Pink Sheet Price Outlook Analysis

Notes

Syros Pharmaceuticals Hype Timeline

Syros Pharmaceuticals is at this time traded for 0.0008. The entity has historical hype elasticity of 0.46, and average elasticity to hype of competition of -6.29. Syros is projected to increase in value after the next headline, with the price projected to jump to 8.33E-4 or above. The average volatility of media hype impact on the company the price is over 100%. The price appreciation on the next news is estimated to be 4.16%, whereas the daily expected return is at this time at 23.03%. The volatility of related hype on Syros Pharmaceuticals is about 33769.23%, with the expected price after the next announcement by competition of -6.29. Syros Pharmaceuticals currently holds about 244.48 M in cash with (109.71 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 12.09, which can makes it an attractive takeover target, given it will continue generating positive cash flow. Given the investment horizon of 90 days the next projected press release will be in about 20 days. Check out Historical Fundamental Analysis of Syros Pharmaceuticals to cross-verify your projections.

Syros Pharmaceuticals Related Hype Analysis

Other Forecasting Options for Syros Pharmaceuticals

For every potential investor in Syros, whether a beginner or expert, Syros Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Syros Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Syros. Basic forecasting techniques help filter out the noise by identifying Syros Pharmaceuticals' price trends.

Syros Pharmaceuticals Related Equities

Risk & Return

Correlation

Syros Pharmaceuticals Market Strength Events

Syros Pharmaceuticals Risk Indicators

Story Coverage note for Syros Pharmaceuticals

Syros Pharmaceuticals Short Properties

Additional Tools for Syros Pink Sheet Analysis